ScholarWorks@Korea University: Lee, Sung Yong

Detailed Information

Lee, Sung Yong (이승룡)

Graduate School (Department of Biomedical Sciences)

Research Area

Tel 구3030
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Nonsmall cell lung cancer:6||nonsmall cell lung cancer:5||Chemotherapy:4||EGFR:3||afatinib:3||Afatinib:3||Procalcitonin:2||epidermal growth factor receptor:2||exacerbation:2||Epidermal growth factor receptor:2||Gefitinib:2||Cisplatin:2||Biomarker:2||EGFR mutation:2||inflammation:2||Cancer vaccine:2||Human papillomavirus:2||tuberculosis:2||Osimertinib:2||Lung cancer:2||Small cell lung carcinoma:2||osimertinib:2||COPD:2||T790M:2||Endoplasmic reticulum stress:1||Pulmonary sarcomatoid carcinoma:1||club cell secretory protein16:1||Pulmonary Disease:1||Extensive stage disease:1||Retinol:1||interleukin27:1||SAHA:1||Antitumor:1||Wild type:1||Factor XIII:1||histological type:1||Cervical cancer:1||PNAmediated PCR clamping method:1||Nonsmallcell lung cancer:1||Paclitaxel:1||squamous cell carcinoma:1||circulating tumor DNA:1||Tyrosine kinase inhibitor:1||Lung neoplasms:1||EGFR T790M:1||Realworld efficacy:1||surfaceenhanced Raman spectroscopy:1||Lung Diseases:1||Bojungikkitang:1||AntiPD1:1||ACO:1||smoking:1||Chronic Obstructive:1||Phase III study:1||Firstline:1||allergen:1||Surgery:1||Acute Lung Injury:1||VentilatorInduced Lung Injury:1||ERCC1:1||Paclitaxelloaded polymeric micelle:1||world:1||lung cancer:1||chemotherapy:1||realworld:1||Early diagnosis:1||Biomarkers:1||real world:1||Bronchiectasis:1||acute exacerbation of COPD:1||Insurance:1||Bisphenol A:1||Bacterial:1||Prognostic factor:1||Mulberry:1||Bortezomib:1||Reactive oxygen species:1||Prognosis:1||Nonsmall cell lung carcinoma:1||Transglutaminase 2:1||Histone deacetylase inhibitor:1||Thymidylate synthase:1||Direct gene sequencing:1||levodropropizine:1||cerebellum metastasis:1||epidermal growth factor receptor (EGFR):1||NSCLC:1||lazertinib:1||NEPTUNE:1||Nonsmallcell lung carcinoma:1||Realworld:1||Interstitial • MDA5 protein:1||zebrafish:1||HPV16:1||GRP78:1||High resolution metabolomics:1||Lung diseases:1||Not available:1||Small cell lung cancer:1||food allergy:1||IgE:1||Host immunity:1||EGFRtyrosine kinase inhibitor:1||Postprogression survival (PPS):1||TAHPV:1||anaphylaxis:1||next&#8208:1||real&#8208:1||EGFR&#8208:1||TKI:1||non&#8208:1||berberine:1||immune checkpoint inhibitor (ICI):1||firstline:1||chemoradiotherapy:1||atezolizumab:1||ErbB receptors:1||randomized controlled trial:1||Realworld date:1||HPV:1||CHOP:1||Treatment outcome:1||Receptor:1||Pseudomonas aeruginosa:1||virus:1||Singleincision technique:1||Belotecan:1||Lproline:1||Skeletalrelated event:1||Vorinostat:1||Firstline chemotherapy:1||Respiration, Artificial:1||Plasma:1||Peptide nucleic acids (PNAs):1||drug allergy:1||rebiopsy:1||Survival:1||chronic bronchitis:1||bronchiectasis:1||nonsmall cell lung cancer (NSCLC):1||realworld data:1||consolidation therapy:1||Noninvasive screening:1||whole exome sequencing:1||Durvalumab:1||cellfree DNA:1||protocol:1||Therapeutic HPV vaccine:1||chronic obstructive pulmonary disease:1||Programmed death ligand 1:1||epidermal growth factor:1||tobacco smoke:1||readmission:1||Complications:1||LCMS:1||nonsmallcell lung carcinoma:1||Vaccinia virus:1||EGER mutation:1||genomic profiling:1||generation sequencing:1||Adenocarcinoma:1||oncogene:1||prognosis:1||plasma cellfree DNA:1||blood tumor mutation burden:1||Atezolizumab:1||3bromopyruvate:1||CD8 T cells:1||acute exacerbation:1||interleukin (IL)6:1||biomarker:1||Implantable venous access port:1||Bone metastases:1||Oxidative stress:1||Inflammation:1||neoplasm staging:1||Vaccine:1||Predictive marker:1||acquired resistance:1||platinum:1||Lung adenocarcinoma:1||Tumor mutational burden:1||Tremelimumab:1||nonsmallcell lung cancer:1||Realworld effectiveness:1||pcDNA3CRT/E7:1||bacterial infection:1||eosinophil:1||asthma:1||bacterium:1||Axillary vein:1||Health:1||Interstitial:1||Pneumonia:1||single nucleotide polymorphism:1||Respiratory Distress Syndrome, Adult:1||Acquired resistance:1||Failure togefitinib:1||Biologic markers:1||Pleural effusion:1||Parapneumonic effusion:1||Pulmonary adenocarcinoma:1||Calreticulin:1||histamine release:1||small cell lung carcinoma:1||hederacoside C:1||mucolytic agent:1||Non–small cell lung cancer:1||Metabolomics:1||Exhaled breath condensate:1||copy number alteration detection:1||Metastatic NSCLC:1||extracellular vesicles:1||pembrolizumab:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE